The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Sharma, R. P.
* Articles by Nemeroff, C. B.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Sharma, R. P.
* Articles by Nemeroff, C. B.
Related Collections
* Neurotransmitters
* Schizophrenia Spectrum Disorders
* Other Neuroleptics

Am J Psychiatry 1997; 154:1019-1021
Copyright © 1997 by American Psychiatric Association


REGULAR ARTICLES

CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder

RP Sharma, PG Janicak, G Bissette and CB Nemeroff
Department of Psychiatry, University of Illinois College of Medicine at Chicago 60612, USA.

OBJECTIVE: The relationship between CSF neurotensin concentrations and measures of psychopathology in patients with schizophrenia or schizoaffective disorder was examined before and after treatment with antipsychotic drugs. METHOD: CSF neurotensin concentrations were measured in 42 drug-free patients with schizophrenia or schizoaffective disorder. For 18 of these patients, CSF neurotensin was measure again after 4 weeks of antipsychotic treatment. RESULTS: Significantly higher levels of pretreatment psychopathology were observed in the patients with the lowest CSF neurotensin concentrations. Furthermore, improvements in overall psychopathology and, particularly, negative symptoms were correlated with increases in CSF neurotensin concentrations during treatment. CONCLUSIONS: These findings provide further evidence for a role of neurotensin the pathophysiology of psychosis and in the mechanism of action of antipsychotic drugs.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
B. Kinkead, P. R. Dobner, V. Egnatashvili, T. Murray, N. Deitemeyer, and C. B. Nemeroff
Neurotensin-Deficient Mice Have Deficits in Prepulse Inhibition: Restoration by Clozapine but Not Haloperidol, Olanzapine, or Quetiapine
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 256 - 264.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
E. B. Binder, B. Kinkead, M. J. Owens, and C. B. Nemeroff
Neurotensin and Dopamine Interactions
Pharmacol. Rev., December 1, 2001; 53(4): 453 - 486.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. R. Dobner, J. Fadel, N. Deitemeyer, R. E. Carraway, and A. Y. Deutch
Neurotensin-deficient mice show altered responses to antipsychotic drugs
PNAS, June 20, 2001; (2001) 141042198.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. B. Binder, B. Kinkead, M. J. Owens, C. D. Kilts, and C. B. Nemeroff
Enhanced Neurotensin Neurotransmission Is Involved in the Clinically Relevant Behavioral Effects of Antipsychotic Drugs: Evidence from Animal Models of Sensorimotor Gating
J. Neurosci., January 15, 2001; 21(2): 601 - 608.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Kinkead, S. Shahid, M. J. Owens, and C. B. Nemeroff
Effects of Acute and Subchronic Administration of Typical and Atypical Antipsychotic Drugs on the Neurotensin System of the Rat Brain
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 67 - 73.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Kinkead, S. M. Lorch, M. J. Owens, and C. B. Nemeroff
Sex- and Estrous Cycle-Related Differences in the Effects of Acute Antipsychotic Drug Administration on Neurotensin-Containing Neurons in the Rat Brain
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 205 - 211.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Radke, M. J. Owens, J. C. Ritchie, and C. B. Nemeroff
Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions
PNAS, September 15, 1998; 95(19): 11462 - 11464.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. R. Dobner, J. Fadel, N. Deitemeyer, R. E. Carraway, and A. Y. Deutch
Neurotensin-deficient mice show altered responses to antipsychotic drugs
PNAS, July 3, 2001; 98(14): 8048 - 8053.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1997 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org